Goldman Sachs’s Moderna MRNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$93.9M Buy
3,403,239
+188,143
+6% +$5.19M 0.01% 788
2025
Q1
$91.1M Sell
3,215,096
-86,639
-3% -$2.46M 0.01% 720
2024
Q4
$137M Sell
3,301,735
-76,113
-2% -$3.16M 0.02% 544
2024
Q3
$226M Sell
3,377,848
-807,710
-19% -$54M 0.04% 406
2024
Q2
$497M Buy
4,185,558
+255,646
+7% +$30.4M 0.08% 197
2024
Q1
$419M Sell
3,929,912
-621,714
-14% -$66.2M 0.07% 232
2023
Q4
$453M Buy
4,551,626
+447,639
+11% +$44.5M 0.08% 202
2023
Q3
$424M Buy
4,103,987
+632,350
+18% +$65.3M 0.09% 177
2023
Q2
$422M Buy
3,471,637
+412,412
+13% +$50.1M 0.09% 176
2023
Q1
$470M Buy
3,059,225
+306,053
+11% +$47M 0.11% 158
2022
Q4
$495M Buy
2,753,172
+1,490,684
+118% +$268M 0.12% 139
2022
Q3
$149M Sell
1,262,488
-1,506,938
-54% -$178M 0.04% 447
2022
Q2
$396M Buy
2,769,426
+1,156,961
+72% +$165M 0.1% 143
2022
Q1
$278M Buy
1,612,465
+313,877
+24% +$54.1M 0.06% 285
2021
Q4
$330M Sell
1,298,588
-286,235
-18% -$72.7M 0.07% 261
2021
Q3
$610M Buy
1,584,823
+122,665
+8% +$47.2M 0.13% 122
2021
Q2
$344M Buy
1,462,158
+406,484
+39% +$95.5M 0.08% 207
2021
Q1
$138M Sell
1,055,674
-103,374
-9% -$13.5M 0.03% 442
2020
Q4
$121M Sell
1,159,048
-659,317
-36% -$68.9M 0.03% 452
2020
Q3
$129M Sell
1,818,365
-788,858
-30% -$55.8M 0.04% 414
2020
Q2
$167M Buy
2,607,223
+1,089,796
+72% +$70M 0.05% 335
2020
Q1
$45.4M Buy
1,517,427
+197,363
+15% +$5.91M 0.02% 846
2019
Q4
$25.8M Buy
1,320,064
+91,314
+7% +$1.79M 0.01% 1439
2019
Q3
$19.6M Buy
1,228,750
+101,293
+9% +$1.61M 0.01% 1540
2019
Q2
$16.5M Sell
1,127,457
-42,988
-4% -$629K ﹤0.01% 1691
2019
Q1
$23.8M Sell
1,170,445
-185,481
-14% -$3.77M 0.01% 1505
2018
Q4
$20.7M Buy
+1,355,926
New +$20.7M 0.01% 1507